Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease-Reference-Cited by-同舟云学术

Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease

Published:2011-03-08 Issue:2 Volume:153 Page:244-252
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Shaw Bronwen E.,Apperley Jane F.,Russell Nigel H.,Craddock Charles,Liakopoulou Effie,Potter Michael N.,Wynn Robert,Gibson Brenda,Pearce Rachel M.,Kirkland Keiren,Lee Julia,Madrigal J. Alejandro,Cook Gordon,Byrne Jennifer L.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08615.x/fullpdf

Reference37 articles.

1. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO);Bacigalupo;Blood,2001

2. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation;Bacigalupo;Biology of Blood and Marrow Transplantation,2006

3. Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study;Blau;Bone Marrow Transplantation,2001

4. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen;Chakraverty;Blood,2002

5. Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis;Craddock;British Journal of Haematology,2001

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts;Transplantation and Cellular Therapy;2023-12

2. Immunotherapy with CD25/CD71-allodepleted T cells to improve T-cell reconstitution after matched unrelated donor hematopoietic stem cell transplant: a randomized trial;Cytotherapy;2023-01

3. T-replete HLA-matched Grafts vs T-depleted HLA-mismatched Grafts in Inborn Errors of Immunity;Blood Advances;2021-12-31

4. Hypomethylating agent-based post-transplant strategies to maximize the outcome of high-risk acute myeloid leukemia after allogeneic stem cell transplantation;Expert Review of Hematology;2020-08-14

5. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD;European Journal of Immunology;2017-10-27